UG Healthcare Corporation Ltd
SGX:8K7
Intrinsic Value
UG Healthcare Corp. Ltd. is an investment holding company, which engages in the manufacture and distribution of natural latex and nitrile examination gloves. [ Read More ]
The intrinsic value of one
8K7
stock under the Base Case scenario is
0.14
SGD.
Compared to the current market price of 0.11 SGD,
UG Healthcare Corporation Ltd
is
Undervalued by 22%.
UG Healthcare Corporation Ltd's market capitalization is 68.6m SGD.
8K7 stock price is 0.11 SGD.
8K7 stock price (0.11 SGD) is 22% less than its Intrinsic Value (0.14 SGD).
8K7 stock (0.1 SGD) is 9% less than its price (0.11 SGD). Open Relative Valuation
8K7 has upside potential of 82% compared to the average analyst price target.
Open Wall St Estimates
8K7 has negative Net Income for the last twelve months.
8K7 has negative Operating Income for the last twelve months.
8K7's Altman Z-Score is equal to 2.41.
8K7 has positive Gross Profit for the last twelve months.
8K7's Revenue has dropped by 45% over the past 12 months.
8K7's ROE (Return on Equity) has significantly decreased in the last 3 years from 80% to -11%.
8K7's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 71% to -19%.
8K7's ROE (Return on Equity) for the past 12 months is negative and is equal to -11%.
8K7 has negative Free Cash Flow for the last twelve months.
8K7's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -19%.
8K7 has very high three-year average ROIC (Return on Invested Capital): 31%. The company is very efficient at using invested capital to generate operating income.
8K7 has very high three-year average ROE (Return on Equity): 33%. The company is very efficient at transforming stockholders' equity into net income.
8K7's Revenue has been falling by 28% per year for the last 3 years.
8K7's D/E (Debt to Equity) is very low and is equal to 0.08.
8K7's short-term assets (160m SGD) exceed its short-term liabilties (33m SGD).
8K7's long-term assets (230m SGD) exceed its long-term liabilties (49m SGD).
8K7 has negative Net Debt. This means that the company has more cash and short-term investments (62m SGD) than debt (14m SGD).
8K7 doesn't generate enough operating income (-24m SGD) to safely cover interest payments on its debt (1m SGD).
Valuation Backtest
UG Healthcare Corporation Ltd
Run backtest to discover the historical profit from buying and selling
8K7
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
UG Healthcare Corporation Ltd
Balance Sheet Decomposition
UG Healthcare Corporation Ltd
| Current Assets | 159.9m |
| Cash & Short-Term Investments | 61.7m |
| Receivables | 43.6m |
| Other Current Assets | 54.5m |
| Non-Current Assets | 70.1m |
| Long-Term Investments | 7.1m |
| PP&E | 59.8m |
| Intangibles | 616k |
| Other Non-Current Assets | 2.6m |
| Current Liabilities | 32.8m |
| Accounts Payable | 14.1m |
| Other Current Liabilities | 18.7m |
| Non-Current Liabilities | 16.4m |
| Long-Term Debt | 14.4m |
| Other Non-Current Liabilities | 2m |
Earnings Waterfall
UG Healthcare Corporation Ltd
|
Revenue
|
94.9m
SGD
|
|
Cost of Revenue
|
-91.5m
SGD
|
|
Gross Profit
|
3.4m
SGD
|
|
Operating Expenses
|
-27.7m
SGD
|
|
Operating Income
|
-24.3m
SGD
|
|
Other Expenses
|
3.4m
SGD
|
|
Net Income
|
-20.9m
SGD
|
Free Cash Flow Analysis
UG Healthcare Corporation Ltd
8K7 Profitability Score
Profitability Due Diligence
UG Healthcare Corporation Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
UG Healthcare Corporation Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
8K7 Solvency Score
Solvency Due Diligence
UG Healthcare Corporation Ltd's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Score
UG Healthcare Corporation Ltd's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
8K7 Price Targets Summary
UG Healthcare Corporation Ltd
According to Wall Street analysts, the average 1-year price target for
8K7
is 0.2 SGD
.
Shareholder Return
8K7 Price
UG Healthcare Corporation Ltd
| Average Annual Return | 268.93% |
| Standard Deviation of Annual Returns | 608.71% |
| Max Drawdown | -98% |
| Market Capitalization | 68.6m SGD |
| Shares Outstanding | 623 825 811 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
UG Healthcare Corporation Ltd
Country
Industry
Market Cap
Dividend Yield
Description
UG Healthcare Corp. Ltd. is an investment holding company, which engages in the manufacture and distribution of natural latex and nitrile examination gloves. The company is headquartered in Seremban, Negeri Sembilan. The company went IPO on 2014-12-08. The principal activity of the Company is investment holding. The firm operates through three segments: latex examination gloves, nitrile examination gloves and other ancillary products. The firm operates primarily in Malaysia, Brazil, Germany, United Kingdom, China and United States. The firm sells its disposable gloves under its Unigloves brand. The company also distributes ancillary products, including surgical, vinyl, and cleanroom disposable gloves, as well as non-glove products such as face masks and medical disposables. The company operates two manufacturing facilities in Seremban, Negeri Sembilan, Malaysia. The firm's subsidiaries include N.S. Uni-Gloves Sdn Bhd, UG Global Resources Sdn Bhd, UG Glovetech Sdn Bhd, Unigloves (Singapore) Pte Ltd, UGHC Marketing Pte Ltd and UG Engineering Sdn Bhd.
Contact
IPO
Employees
Officers
The intrinsic value of one
8K7
stock under the Base Case scenario is
0.14
SGD.
Compared to the current market price of 0.11 SGD,
UG Healthcare Corporation Ltd
is
Undervalued by 22%.
You don't have any saved screeners yet
